Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - RESEARCH & DEVELOPMENT
Research & Development VRDN - Viridian Therapeutics, Inc.
160 M
LAST VALUE
67.59%
2 YEAR CAGR
39.34%
5 YEAR CAGR
109.77%
10 YEAR CAGR